» Articles » PMID: 24496315

Blockade of IL-33 Release and Suppression of Type 2 Innate Lymphoid Cell Responses by Helminth Secreted Products in Airway Allergy

Overview
Journal Mucosal Immunol
Publisher Elsevier
Date 2014 Feb 6
PMID 24496315
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H. polygyrus (HES) potently suppress inflammation induced by allergens from the common fungus Alternaria alternata. Alternaria extract, when administered to mice intranasally with ovalbumin (OVA) protein, induces a rapid (1-48 h) innate response while also priming an OVA-specific Th2 response that can be evoked 14 days later by intranasal administration of OVA alone. In this model, HES coadministration with Alternaria/OVA suppressed early IL-33 release, innate lymphoid cell (ILC) production of IL-4, IL-5, and IL-13, and localized eosinophilia. Upon OVA challenge, type 2 ILC (ILC2)/Th2 cytokine production and eosinophilia were diminished in HES-treated mice. HES administration 6 h before Alternaria blocked the allergic response, and its suppressive activity was abolished by heat treatment. Administration of recombinant IL-33 at sensitization with Alternaria/OVA/HES abrogated HES suppression of OVA-specific responses at challenge, indicating that suppression of early Alternaria-induced IL-33 release could be central to the anti-allergic effects of HES. Thus, this helminth parasite targets IL-33 production as part of its armory of suppressive effects, forestalling the development of the type 2 immune response to infection and allergic sensitization.

Citing Articles

Nematode serine protease inhibitor SPI-I8 negatively regulates host NF-κB signalling by hijacking MKRN1-mediated polyubiquitination of RACK1.

Wu F, Chen Y, Chen X, Tong D, Zhou J, Du Z Commun Biol. 2025; 8(1):356.

PMID: 40032982 PMC: 11876351. DOI: 10.1038/s42003-025-07803-8.


Structural basis for IL-33 recognition and its antagonism by the helminth effector protein HpARI2.

Jamwal A, Colomb F, McSorley H, Higgins M Nat Commun. 2024; 15(1):5226.

PMID: 38890291 PMC: 11189471. DOI: 10.1038/s41467-024-49550-0.


TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation.

Schmitt P, Duval A, Camus M, Lefrancais E, Roga S, Dedieu C J Exp Med. 2024; 221(6).

PMID: 38597952 PMC: 11010340. DOI: 10.1084/jem.20231236.


IL-33-binding HpARI family homologues with divergent effects in suppressing or enhancing type 2 immune responses.

Colomb F, Ogunkanbi A, Jamwal A, Dong B, Maizels R, Finney C Infect Immun. 2024; 92(3):e0039523.

PMID: 38294241 PMC: 10929406. DOI: 10.1128/iai.00395-23.


Extracellular derivatives for bone metabolism.

Wu Y, Song P, Wang M, Liu H, Jing Y, Su J J Adv Res. 2024; 66:329-347.

PMID: 38218580 PMC: 11674789. DOI: 10.1016/j.jare.2024.01.011.


References
1.
Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

2.
Klein Wolterink R, Kleinjan A, van Nimwegen M, Bergen I, de Bruijn M, Levani Y . Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol. 2012; 42(5):1106-16. DOI: 10.1002/eji.201142018. View

3.
Luthi A, Cullen S, McNeela E, Duriez P, Afonina I, Sheridan C . Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity. 2009; 31(1):84-98. DOI: 10.1016/j.immuni.2009.05.007. View

4.
Fanta C . Asthma. N Engl J Med. 2009; 360(10):1002-14. DOI: 10.1056/NEJMra0804579. View

5.
Wilson M, Taylor M, OGorman M, Balic A, Barr T, Filbey K . Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol. 2010; 40(6):1682-96. PMC: 3179601. DOI: 10.1002/eji.200939721. View